Cellectis bioresearch, Helix Biocon collaborate to promote cGPS service in India

Cellectis bioresearch, the specialist in genome customization and subsidiary of Cellectis (Alternext: ALCLS), and Helix BioService & Consultants Pvt Ltd (Helix Biocon), today announced that they will join forces for the promotion of Cellectis bioresearch's meganuclease-based products and services in India. Helix Biocon is a young company comprised of professionals with proven expertise in the field of Life sciences, pharmaceuticals and drug discovery research. The companies will pool their expertise to ensure maximum availability for the innovative cellular Genome Positioning System (cGPS®) lines of products and to promote cell line engineering service for bioproduction.

"Cellectis bioresearch aims to make its products the gold standard in genome customization for the life science community throughout the world," said Luc Selig, VP Sales & Marketing at Cellectis bioresearch. "India, as a major player in bioproduction, is a key market for our cell line engineering services. This new collaboration with Helix Biocon will bring our full line of products and services to the growing Indian science community."

Cellectis bioresearch's portfolio today offers over 100 product references, addressing the major needs for genome customization of the life science community.

"We believe Cellectis bioresearch has exciting product lines for top level researchers in pharmaceutical, drug discovery and academia and is poised to redefine genome engineering," said R. Agarwal, Business Director of Helix Biocon. "By providing the cGPS® lines of products coupled with Cellectis' technology transfer and partnership services, Helix Biocon shall be able to offer game changing tools to our Indian customers to assist them in the pursuit of tomorrow's most important scientific discoveries."